Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 FIC index of antibiotic (gentamicin/oxacillin) and Triphala for the MDR bacterial isolates

From: Synergistic activity between Triphala and selected antibiotics against drug resistant clinical isolates

Isolate FIC of antibiotic FIC of Triphala FIC index Interpretation
Gentamicin and Triphala
S. liquefaciens <  0.016 <  0.25 <  0.266 Synergistic
S. odorifera biogroup 1 0.125 0.25 0.375 Synergistic
S. marcescens <  0.5 0.25 <  0.75 Synergistic
Proteus spp. <  0.016 0.25 <  0.27 Synergistic
K. pneumonia 1 0.125 0.25 0.375 Synergistic
K. pneumonia 2 0.031 0.25 0.281 Synergistic
K. pneumonia 3 0.031 0.5 0.531 Synergistic
E. cloacae 0.125 0.5 0.625 Synergistic
Acinetobacter spp. 1 <  0.031 0.25 <  0.281 Synergistic
Acinetobacter spp. 2 <  0.125 0.061 <  0.186 Synergistic
P. aeruginosa 1 0.5 0.5 1 Additive
P. aeruginosa 2 0.5 0.13 0.63 Synergistic
Oxacillin and Triphala
 MRSA 1 <  0.06 0.25 <  0.31 Synergistic
 MRSA 2 0.06 0.5 0.56 Synergistic
 MRSA 3 <  0.016 0.5 <  0.516 Synergistic
 MRSA 4 <  0.25 0.25 <  0.5 Synergistic
 MRSA 5 0.125 0.5 0.625 Synergistic